11. Overview of all interventions in the moderate pain relief analysis.
| Treatment | RCTs | Participants |
| Antidepressants with ≥ 200 participants | ||
| Duloxetine | 24 | 4562 |
| Esreboxetine | 2 | 965 |
| Milnacipran | 7 | 1928 |
| Mirtazapine | 2 | 238 |
| Antidepressants with < 200 participants (excluded from summaries) | ||
| Amitriptyline | 2 | 80 |
| Desipramine | 1 | 37 |
| Desipramine + cognitive behavioural therapy | 1 | 37 |
| Imipramine | 2 | 113 |
| Imipramine + pregabalin | 1 | 69 |
| Venlafaxine | 1 | 86 |
| Non‐antidepressant interventions (excluded from summaries) | ||
| Carbamazepine | 2 | 85 |
| Cognitive behavioural therapy | 2 | 53 |
| Gabapentin | 1 | 22 |
| Pregabalin | 4 | 680 |
| Terbutaline | 1 | 39 |
|
RCT: randomised controlled trial Participant numbers reflect the total number of participants receiving the antidepressant. | ||